drugset
drugset / Trial / NCT05917145

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

NCT05917145 ↗

Phase 1 Recruiting 94 enrolled Mayo Clinic
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to test WSD0628 in combination with radiation therapy for recurrent brain tumors.

Timeline

Start
2024-01-17
Primary completion
2028-05-31
Completion
2029-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject WSD0628 Small molecule — —

Indications

glioblastoma